Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 WYETH   MYLAN
EQUITY SHARE DATA
    WYETH
Mar-14
MYLAN
Dec-18
WYETH/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,0653,945-   
Low Rs5532,171-   
Sales per share (Unadj.) Rs289.51,815.3-  
Earnings per share (Unadj.) Rs38.749.3-  
Cash flow per share (Unadj.) Rs39.9389.2-  
Dividends per share (Unadj.) Rs145.000-  
Avg Dividend yield %17.90-  
Book value per share (Unadj.) Rs118.51,963.8-  
Shares outstanding (eoy) m22.72514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.81.7 165.9%   
Avg P/E ratio x20.962.0 33.7%  
P/CF ratio (eoy) x20.37.9 258.0%  
Price / Book Value ratio x6.81.6 438.3%  
Dividend payout %374.70-   
Avg Mkt Cap Rs m18,3811,573,481 1.2%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m3590-   
Avg. sales/employee Rs Th026,685.0-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0724.6-  
INCOME DATA
Net Sales Rs m6,577933,975 0.7%  
Other income Rs m3470-   
Total revenues Rs m6,925933,975 0.7%   
Gross profit Rs m1,023241,678 0.4%  
Depreciation Rs m27174,877 0.0%   
Interest Rs m444,921 0.0%   
Profit before tax Rs m1,33921,880 6.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m460-3,481 -13.2%   
Profit after tax Rs m87925,361 3.5%  
Gross profit margin %15.625.9 60.1%  
Effective tax rate %34.3-15.9 -215.8%   
Net profit margin %13.42.7 492.3%  
BALANCE SHEET DATA
Current assets Rs m3,964521,531 0.8%   
Current liabilities Rs m2,081380,253 0.5%   
Net working cap to sales %28.615.1 189.3%  
Current ratio x1.91.4 138.9%  
Inventory Days Days3584 42.0%  
Debtors Days Days27893 297.5%  
Net fixed assets Rs m878181,176 0.5%   
Share capital Rs m227497 45.7%   
"Free" reserves Rs m2,4660-   
Net worth Rs m2,6931,010,390 0.3%   
Long term debt Rs m251,090,535 0.0%   
Total assets Rs m4,8422,710,259 0.2%  
Interest coverage x306.01.5 20,575.2%   
Debt to equity ratio x01.1 0.9%  
Sales to assets ratio x1.40.3 394.2%   
Return on assets %18.22.6 703.7%  
Return on equity %32.62.5 1,300.7%  
Return on capital %49.43.2 1,554.3%  
Exports to sales %0.10-   
Imports to sales %34.70-   
Net fx Rs m-2,2910-   
CASH FLOW
From Operations Rs m1,188194,080 0.6%  
From Investments Rs m287-100,318 -0.3%  
From Financial Activity Rs m-4,296-90,414 4.8%  
Net Cashflow Rs m-2,8211,608 -175.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 82.88 Rs / USD

Compare WYETH With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare WYETH With: PLETHICO PHARMA  VISTA PHARMA  SHAMROCK IND  AAYUSH FOOD & HERBS   DECIPHER LABS  



Today's Market

Sensex Today Tanks 735 Points | IT & FMCG Stocks Drag | 5 Reasons Why Indian Share Market is Falling Sensex Today Tanks 735 Points | IT & FMCG Stocks Drag | 5 Reasons Why Indian Share Market is Falling(Closing)

After opening the negative note, Indian share markets continued the downtrend as the session progressed and ended the day weak.